Robert R. Orr
Expertise in
7
conditions

Dr. Robert R. Orr

Pulmonary Medicine
Phoenix Medical Group PC
9171 W Thunderbird Rd Ste 101, 
Peoria,, AZ 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
7
conditions
Phoenix Medical Group PC
9171 W Thunderbird Rd Ste 101, 
Peoria,, AZ 

Overview

Robert Orr is a Pulmonary Medicine provider practicing medicine in Peoria,, Arizona.

Dr. Orr is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Emphysema, Bullae, Pleural Effusion, and Obstructive Sleep Apnea.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 7 clinical trials. Dr. Orr is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Critical Care Medicine in AZ

Hospital Affiliations

Banner Boswell Medical Center

Languages Spoken

English
Farsi
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EMI Health
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Phoenix Medical Group PC
9171 W Thunderbird Rd Ste 101, Peoria,, AZ 85381

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-blind, Placebo-controlled, Multiple-Dose, Study to Assess the Safety, Tolerability, PK and PD After 4 Weeks of Once Weekly Sc. Inj. of PB1046 in Adults With Stable HFrEF, and in Subjects With Cardiac Dysfunction Secondary to DMD
Randomized, Double-blind, Placebo-controlled, Multiple-Dose, Study to Assess the Safety, Tolerability, PK and PD After 4 Weeks of Once Weekly Sc. Inj. of PB1046 in Adults With Stable HFrEF, and in Subjects With Cardiac Dysfunction Secondary to DMD
Enrollment Status: Completed
Publish Date: July 14, 2022
Intervention Type: Drug
Study Phase: Phase 2
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
2016-11: Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
2016-11: Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

3 Total Publications

Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial.
Performance of the microINR Point-of-Care System Used by Self-Testing Patients: A Multicenter Clinical Trial.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: June 21, 2021
Similar Doctors
Expertise in
24
conditions
Dr. Rajat Walia
Pulmonary Medicine | Transplant Surgery
Expertise in
24
conditions
Dr. Rajat Walia
Pulmonary Medicine | Transplant Surgery
Referral required
Before you request

Sjhmc Physician Services

3555 S Val Vista Dr, 
Gilbert, AZ 
 (36.6 miles away)
480-728-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

The Center for Thoracic Disease and Transplantation at the Heart & Lung Institute believes in treating all patients with dignity and respect. Using a multidisciplinary approach, the Center works to diagnose and treat some of the most complex thoracic and esophageal diseases in the Southwest through a team of physicians who provide patients with a plan of care. Patients receive treatment with state-of-the-art technology to ensure a full range of treatment options.We offer treatment and care in accordance with national guidelines. Dr. Walia is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Tissue Biopsy. Dr. Walia is board certified in Internal Medicine (Sub: Critical Care Medicine), Internal Medicine, and Internal Medicine (Sub: Pulmonary Disease). Dr. Walia is currently accepting new patients.

Expertise in
29
conditions
Dr. Craig M. Rundbaken
Pulmonary Medicine
Expertise in
29
conditions
Dr. Craig M. Rundbaken
Pulmonary Medicine
Referral may be required

Goodman Dermatology And Mohs Surgery PLLC

13830 W Camino Del Sol Ste 240, 
Sun City West, AZ 
 (8.2 miles away)
623-975-0500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Craig Rundbaken is a Pulmonary Medicine provider practicing medicine in Sun City West, Arizona. Dr. Rundbaken is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Coccidioidomycosis, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, and Advanced Bronchoscopy. Dr. Rundbaken is currently accepting new patients.

Expertise in
16
conditions
Dr. Rajeev C. Saggar
Pulmonary Medicine
Expertise in
16
conditions
Dr. Rajeev C. Saggar
Pulmonary Medicine
Referral may be required
Before you request

Banner-University Super Specialists LLC

755 E McDowell Rd Fl 4, 
Phoenix, AZ 
 (15.6 miles away)
602-255-7600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rajeev Saggar is a Pulmonary Medicine provider practicing medicine in Phoenix, Arizona. Dr. Saggar is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Saggar is currently accepting new patients.

Frequently Asked Questions about Dr. Robert R. Orr

How do I make an appointment with Dr. Robert R. Orr?

You can book an appointment with Dr. Robert R. Orr by calling their office at 623-815-7800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert R. Orr a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert R. Orr is classified as an Distinguished expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert R. Orr specialize in?

While Dr. Robert R. Orr is a Pulmonary Medicine, they have specific expertise in Emphysema, Bullae, and Pleural Effusion. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Robert R. Orr participate in research or clinical trials?

Yes. Dr. Robert R. Orr has published 3 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Robert R. Orr's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert R. Orr accept my insurance?

Dr. Robert R. Orr accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 623-815-7800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Orr's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile